In developing this automated cell therapy processing platform, Limula’s founders aim to create a disruptive production ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Dr. Radhakrishnan brings significant experience in product development and commercialization that will be particularly valuable as Candel prepares for its Biologics License Application (BLA) ...

Shares of the biotech Kymera Therapeutics are up 50% since Monday, when data from an early trial hinted that its pill might ...

Marketed as BNT327, the PD-L1xVEGF-A bispecific antibody has the potential to become what the involved parties believe is a ...

After years of stagnation, Gilead is betting that a twice-yearly HIV shot can restart its growth engine.

The company is one of the first to receive a “platform technology designation,” which could speed the review of certain gene ...

TAO price holds steady around $410–$420 in June 2025 as Bittensor expands AI subnets and gains institutional support.

Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...

The CDMO's head of development talks about ADCs, accelerated timelines, and the push for end-to-end development services.

AI will deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional ...

CAMBRIDGE, MASS. — The US Department of Health and Human Services (HHS) notified pharmaceutical company Moderna Inc. on May ...